Renapath
NDC 64578-0103, Benzoicum Acidum, Berberis Vulgaris, Bryonia, DNA, Eupatorium Purpureum, Glandula Suprarenalis Suis, Hydrangea Arborescens, Hypothalamus, Mercurius Corrosivus, Pancreas Suis, Pareira Brava, Petroselinum Sativum, Pituitarum Posterium, Rubia Tinctorum, Sarsaparilla, Solidago Virgaurea, Thyroidinum (Bovine), Uva-Ursi, liquid, from Energetix Corporation.
- Product NDC
- 64578-0103
- Status
- Listed
- Labeler
- Energetix Corporation
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64578-0103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CHONDRODENDRON TOMENTOSUM ROOT10 [hp_X]/mL
- PETROSELINUM CRISPUM4 [hp_X]/mL
- SUS SCROFA PITUITARY GLAND12 [hp_X]/mL
- RUBIA TINCTORUM ROOT6 [hp_X]/mL
- SARSAPARILLA4 [hp_X]/mL
- SOLIDAGO VIRGAUREA FLOWERING TOP4 [hp_X]/mL
- THYROID, BOVINE9 [hp_X]/mL
- ARCTOSTAPHYLOS UVA-URSI LEAF4 [hp_X]/mL
- BENZOIC ACID10 [hp_X]/mL
- BERBERIS VULGARIS ROOT BARK4 [hp_X]/mL
- BRYONIA ALBA ROOT12 [hp_X]/mL
- HERRING SPERM DNA12 [hp_X]/mL
- EUTROCHIUM PURPUREUM ROOT12 [hp_X]/mL
- SUS SCROFA ADRENAL GLAND9 [hp_X]/mL
- HYDRANGEA ARBORESCENS ROOT4 [hp_X]/mL
- BOS TAURUS HYPOTHALAMUS12 [hp_X]/mL
- MERCURIC CHLORIDE12 [hp_X]/mL
- SUS SCROFA PANCREAS9 [hp_X]/mL
Pharmacologic classes
Ammonium Ion Binding Activity [MoA]; Nitrogen Binding Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64578-0103-1 | 64578010301 | 59.1 mL in 1 BOTTLE, DROPPER (64578-0103-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 64578-0103 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64578-0103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64578-0103. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.